Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Children and Drug Safety : Balancing Risk and Protection in Twentieth-Century America / / Cynthia A Connolly
| Children and Drug Safety : Balancing Risk and Protection in Twentieth-Century America / / Cynthia A Connolly |
| Autore | Connolly Cynthia A |
| Pubbl/distr/stampa | New Brunswick, NJ : , : Rutgers University Press, , [2018] |
| Descrizione fisica | 1 online resource (p. ) |
| Disciplina | 615.1083 |
| Collana | Critical Issues in Health and Medicine |
| Soggetto topico |
History, 20th Century
Health Policy - history Drug and Narcotic Control - history Drug Therapy - standards Child Drug Therapy - history |
| Soggetto genere / forma | Electronic books. |
| Soggetto non controllato |
children medication
children drug safety drug drugs children medication pharmaceutical pharmacy pills therapy |
| ISBN | 0-8135-6389-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Frontmatter -- Contents -- 1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- 4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- 5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- 6. Children and Psychopharmacology in Postwar America -- 7. Pediatric Drug Development and Policy after 1979 -- Appendix -- Acknowledgments -- Notes -- Index -- About the Author |
| Record Nr. | UNISA-996449437403316 |
Connolly Cynthia A
|
||
| New Brunswick, NJ : , : Rutgers University Press, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Children and Drug Safety : Balancing Risk and Protection in Twentieth-Century America / / Cynthia A Connolly
| Children and Drug Safety : Balancing Risk and Protection in Twentieth-Century America / / Cynthia A Connolly |
| Autore | Connolly Cynthia A |
| Pubbl/distr/stampa | New Brunswick, NJ : , : Rutgers University Press, , [2018] |
| Descrizione fisica | 1 online resource (p. ) |
| Disciplina | 615.1083 |
| Collana | Critical Issues in Health and Medicine |
| Soggetto topico |
History, 20th Century
Health Policy - history Drug and Narcotic Control - history Drug Therapy - standards Child Drug Therapy - history |
| Soggetto genere / forma | Electronic books. |
| Soggetto non controllato |
children medication
children drug safety drug drugs children medication pharmaceutical pharmacy pills therapy |
| ISBN | 0-8135-6389-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Frontmatter -- Contents -- 1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- 4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- 5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- 6. Children and Psychopharmacology in Postwar America -- 7. Pediatric Drug Development and Policy after 1979 -- Appendix -- Acknowledgments -- Notes -- Index -- About the Author |
| Record Nr. | UNINA-9910524871703321 |
|
Connolly Cynthia A
|
||
| New Brunswick, NJ : , : Rutgers University Press, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Children on the Move : The Health of Refugee, Immigrant and Displaced Children / / Charles Oberg, editor
| Children on the Move : The Health of Refugee, Immigrant and Displaced Children / / Charles Oberg, editor |
| Pubbl/distr/stampa | Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2020 |
| Descrizione fisica | 1 online resource (142 pages) |
| Disciplina | 615.1083 |
| Soggetto topico |
Pediatric pharmacology
Drugs |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Children on the Move |
| Record Nr. | UNINA-9910674048403321 |
| Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug development and rare pediatric diseases : issues, strategic plan, and voucher program assessment / / Frederick Johnston, editor
| Drug development and rare pediatric diseases : issues, strategic plan, and voucher program assessment / / Frederick Johnston, editor |
| Pubbl/distr/stampa | New York, [New York] : , : Nova Biomedical, , 2016 |
| Descrizione fisica | 1 online resource (140 pages) : illustrations, tables |
| Disciplina | 615.1083 |
| Collana | Pharmacology - Research, Safety Testing and Regulation |
| Soggetto topico |
Pediatric pharmacology
Drug development Children - Diseases - Treatment |
| ISBN | 1-5361-0228-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910136575003321 |
| New York, [New York] : , : Nova Biomedical, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicating foster care children with psychotropic drugs : an examination / / Robert L. Ray and Mackenzie A. Watkins, editors
| Medicating foster care children with psychotropic drugs : an examination / / Robert L. Ray and Mackenzie A. Watkins, editors |
| Pubbl/distr/stampa | New York : , : Nova Publishers, , 2012 |
| Descrizione fisica | 1 online resource (130 pages) : illustrations |
| Disciplina | 615.1083 |
| Collana | Children's Issues, Laws and Programs |
| Soggetto topico |
Pediatric pharmacology
Psychotropic drugs Foster children - United States |
| ISBN | 1-61942-910-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Foster children : HHS guidance could help states improve oversight of psychotropic prescriptions / United States Government Accountability Office -- Medicating foster children hearing : Brown statement / Scott Brown -- Medicating foster children hearing : Samuels testimony / Bryan Samuels -- Medicating foster children hearing : Salo testimony / Matt Salo -- Medicating foster children hearing : McClellan testimony / Jon McClellan. |
| Record Nr. | UNINA-9910155023603321 |
| New York : , : Nova Publishers, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric clinical pharmacology / Hannsjörg W. Seyberth, Anders Rane, Matthias Schwab, editors
| Pediatric clinical pharmacology / Hannsjörg W. Seyberth, Anders Rane, Matthias Schwab, editors |
| Pubbl/distr/stampa | New York : Springer, 2011 |
| Descrizione fisica | XII, 383 p. ; 24 cm |
| Disciplina | 615.1083 |
| Collana | Handbook of Experimental Pharmacologhy |
| Soggetto topico | Pediatria - Impiego [dei] Farmaci |
| ISBN | 978-3-642-20194-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-990003585600203316 |
| New York : Springer, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Pediatric Pharmacotherapy / / edited by Wieland Kiess, Matthias Schwab, Johannes van den Anker
| Pediatric Pharmacotherapy / / edited by Wieland Kiess, Matthias Schwab, Johannes van den Anker |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (VIII, 538 p. 1 illus.) |
| Disciplina | 615.1083 |
| Collana | Handbook of Experimental Pharmacology |
| Soggetto topico |
Pharmacology
Pediatrics Quimioteràpia Pediatria |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-50494-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Anti-epileptic drugs in pediatrics -- Current and new therapies for Duchenne Muscular Dystrophy -- Lysosomal diseases -- Mitochondriopathies -- Endocrinology thyroid, pituitary, growth stimulant, growth reduction -- Bone disease – bisphosphonates -- Diabetes type 1 and 3 (insulin; sulfonylurea; others) -- Diabetes type 2 (metformin etc.) -- Dermatology – part 1 urticaria, atopic dermatitis -- Dermatology part 2, ichtyosis, psoriasis -- Cardiovascular part 1- catcholamines, inotropic -- Cardiovascular part 2 – antiarhythmica, anti hypertensives -- Nephrology – dialysis -- How to use drugs in obese children and adolescents -- Haematology – CSFs, erythropoietin -- Antiretroviral/HIV -- Clinical pharmacology and pharmacometrics to better understand physiological changes during pregnancy and neonatal life -- Antihelminth treatment -- Inflammatory bowel disease -- Constipation; laxatives -- Psychiatric diseases in children and adolescents -- Oncology – cell reducing agents part 1, part 2, part 3 -- Immunosuppressants – organ transplantation -- Bone marrow/stem cell transplantation -- Narcotic sparing approaches and the shift towards paracetamol in neonatal intensive care -- Disorders of puberty: pharmacotherapeutic strategies for management. |
| Record Nr. | UNINA-9910416107603321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric pharmacotherapy self assessment / / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others]
| Pediatric pharmacotherapy self assessment / / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others] |
| Autore | Benavides Sandra |
| Pubbl/distr/stampa | Bethesda, Maryland : , : ASHP Publications, , 2015 |
| Descrizione fisica | 1 online resource (285 p.) |
| Disciplina | 615.1083 |
| Soggetto topico | Pediatric pharmacology |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-58528-426-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""titlepage""; ""table of contents""; ""contributors""; ""preface""; ""acknowledgments""; ""1.1 Pediatric Patient Care Management""; ""Part One - Cases""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2""; ""CASE 3.3 Congenital Heart Defects | Level 3""; ""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""
""CASE 5.2 Crohn Disease | Level 2""""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1""; ""CASE 8.2 Autism Spectrum Disorder | Level 2""; ""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1"" ""CASE 9.3 Parasitic Infections | Level 2""""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3""; ""PART 2 | QUESTIONS & ANSWERS""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2"" ""CASE 3.3 Congenital Heart Defects | Level 3""""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""; ""CASE 5.2 Crohn Disease | Level 2""; ""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1"" ""CASE 8.2 Autism Spectrum Disorder | Level 2""""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1""; ""CASE 9.3 Parasitic Infections | Level 2""; ""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3"" ""APPENDIXES"" |
| Record Nr. | UNINA-9910459912303321 |
|
Benavides Sandra
|
||
| Bethesda, Maryland : , : ASHP Publications, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric pharmacotherapy self assessment / / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others]
| Pediatric pharmacotherapy self assessment / / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others] |
| Autore | Benavides Sandra |
| Pubbl/distr/stampa | Bethesda, Maryland : , : ASHP Publications, , 2015 |
| Descrizione fisica | 1 online resource (285 p.) |
| Disciplina | 615.1083 |
| Soggetto topico | Pediatric pharmacology |
| ISBN | 1-58528-426-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""titlepage""; ""table of contents""; ""contributors""; ""preface""; ""acknowledgments""; ""1.1 Pediatric Patient Care Management""; ""Part One - Cases""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2""; ""CASE 3.3 Congenital Heart Defects | Level 3""; ""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""
""CASE 5.2 Crohn Disease | Level 2""""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1""; ""CASE 8.2 Autism Spectrum Disorder | Level 2""; ""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1"" ""CASE 9.3 Parasitic Infections | Level 2""""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3""; ""PART 2 | QUESTIONS & ANSWERS""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2"" ""CASE 3.3 Congenital Heart Defects | Level 3""""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""; ""CASE 5.2 Crohn Disease | Level 2""; ""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1"" ""CASE 8.2 Autism Spectrum Disorder | Level 2""""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1""; ""CASE 9.3 Parasitic Infections | Level 2""; ""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3"" ""APPENDIXES"" |
| Record Nr. | UNINA-9910787126103321 |
|
Benavides Sandra
|
||
| Bethesda, Maryland : , : ASHP Publications, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric pharmacotherapy self assessment / / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others]
| Pediatric pharmacotherapy self assessment / / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others] |
| Autore | Benavides Sandra |
| Pubbl/distr/stampa | Bethesda, Maryland : , : ASHP Publications, , 2015 |
| Descrizione fisica | 1 online resource (285 p.) |
| Disciplina | 615.1083 |
| Soggetto topico | Pediatric pharmacology |
| ISBN | 1-58528-426-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""titlepage""; ""table of contents""; ""contributors""; ""preface""; ""acknowledgments""; ""1.1 Pediatric Patient Care Management""; ""Part One - Cases""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2""; ""CASE 3.3 Congenital Heart Defects | Level 3""; ""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""
""CASE 5.2 Crohn Disease | Level 2""""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1""; ""CASE 8.2 Autism Spectrum Disorder | Level 2""; ""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1"" ""CASE 9.3 Parasitic Infections | Level 2""""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3""; ""PART 2 | QUESTIONS & ANSWERS""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2"" ""CASE 3.3 Congenital Heart Defects | Level 3""""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""; ""CASE 5.2 Crohn Disease | Level 2""; ""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1"" ""CASE 8.2 Autism Spectrum Disorder | Level 2""""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1""; ""CASE 9.3 Parasitic Infections | Level 2""; ""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3"" ""APPENDIXES"" |
| Record Nr. | UNINA-9910808183403321 |
|
Benavides Sandra
|
||
| Bethesda, Maryland : , : ASHP Publications, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
